Universitatsklinikum Schleswig-Holstein

Lübeck, Schleswig-Holstein 23562

1 studies enrolling now · 4 studies all time

What they study most

Atopic Dermatitis, BRAF or NRAS Mutant Metastatic Melanoma, Hepatocellular Carcinoma (HCC), Moderate Psoriasis, Plaque Psoriasis, Psoriasis, Psoriasis (PsO), Severe Psoriasis

Studies at this site

• A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206) — Recruiting now
• Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis — Running, not enrolling
• A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma — Completed
• Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis — Completed